๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

โœ Scribed by Masakuni Tateyama; Hiroshi Yatsuhashi; Naota Taura; Yasuhide Motoyoshi; Shinya Nagaoka; Kenji Yanagi; Seigo Abiru; Koji Yano; Atsumasa Komori; Kiyoshi Migita; Minoru Nakamura; Hiroyasu Nagahama; Yutaka Sasaki; Yuzo Miyakawa; Hiromi Ishibashi


Publisher
Springer Japan
Year
2010
Tongue
English
Weight
290 KB
Volume
46
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Hepatic steatosis is a risk factor for h
โœ Kazuyuki Ohata; Keisuke Hamasaki; Kan Toriyama; Kojiro Matsumoto; Akira Saeki; K ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB ๐Ÿ‘ 3 views

## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of

Serum insulin-like growth factor I evalu
โœ Gherardo Mazziotti; Francesca Sorvillo; Filomena Morisco; Antonella Carbone; Mar ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 3 views

## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first

Case-control study on hepatitis C virus
โœ Alessandro Tagger; Francesco Donato; Maria L. Ribero; Roberta Chiesa; Giuseppe P ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 70 KB ๐Ÿ‘ 3 views

We performed a case-control study to evaluate the risk of hepatocellular carcinoma (HCC) for hepatitis C virus (HCV) infection. A total of 305 newly diagnosed HCC cases (80% males) and 610 subjects (81% males) unaffected by clinically evident hepatic disease admitted to the 2 main hospitals in Bresc